Review

The Role of Skeletal Muscle Sphingolipids in the Development of Insulin Resistance

Marek Straczkowski, Irina Kowalska

Manuscript submitted May 22, 2008; accepted May 29, 2008.

Keywords: type 2 diabetes, insulin resistance, skeletal muscle, lipids, ceramide, obesity, free fatty acids

Abstract

Insulin resistance is an important risk factor for type 2 diabetes, obesity, cardiovascular disease, polycystic ovary syndrome and other diseases. The most important stage in the development of insulin resistance is impairment of insulin-stimulated skeletal muscle glucose uptake. There is evidence that intramyocellular lipids might be responsible for this process through inhibition of insulin signaling. One of the important intracellular lipid pools is associated with the sphingomyelin signaling pathway. The second messenger in this pathway is ceramide. In vitro data indicate that ceramide inhibits insulin signaling, mainly through inactivation of protein kinase B. In vivo data suggest that ceramide accumulation within muscle cells might be associated with the development of insulin resistance. In this review, we discuss both in vitro and in vivo evidence for the role of muscle ceramide in the impairment of insulin action with particular focus on the question whether findings from animal studies are applicable to humans. We describe problems that are unresolved so far and topics of potential interest for future research.

Fulltext: HTML , PDF (371KB)

This article has been cited by other articles:

	Ceramide-mediated insulin resistance and impairment of cognitive-motor functions de la Monte SM, Tong M, Nguyen V, Setshedi M, Longato L, Wands JR J Alzheimers Dis 2010. 21(3):967-984
	Sphingolipids and insulin resistance: the five Ws Summers SA Curr Opin Lipidol 2010. 21(2):128-135
	Associations of energy intake and type 2 diabetes with hypertryglyceridemia in older adults living in the Mediterranean Islands: The Medis Study Tyrovolas S, Pounis G, Zeimbekis A, Antonopoulou M, Bountziouka V, Gotsis E, Metallinos G, Polystipioti A, Polychronopoulos E, Lionis C, Panagiotakos DB J Nutr Elder 2010. 29(1):72-86
	Skeletal muscle insulin resistance in endocrine disease Peppa M, Koliaki C, Nikolopoulos P, Raptis SA J Biomed Biotechnol 2010. 2010:527850
	Ceramides: A new player in the inflammation-insulin resistance paradigm? Gill JM, Sattar N Diabetologia 2009. 52(12):2475-2477
	Metabolite profiling identifies candidate markers reflecting the clinical adaptations associated with Roux-en-Y gastric bypass surgery Mutch DM, Fuhrmann JC, Rein D, Wiemer JC, Bouillot JL, Poitou C, Clement K PLoS One 2009. 4(11):e7905
	Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis de la Monte SM, Longato L, Tong M, Wands JR Curr Opin Investig Drugs 2009. 10(10):1049-1060
	Factors Associated with the Prevalence of Diabetes Mellitus Among Elderly Men and Women Living in Mediterranean Islands: The MEDIS Study Tyrovolas S, Zeimbekis A, Bountziouka V, Voutsa K, Pounis G, Papoutsou S, Metallinos G, Ladoukaki E, Polychronopoulos E, Lionis C, Panagiotakos DB Rev Diabet Stud 2009. 6(1):54-63